Tag: CART cells
The Human Stories and Hidden Heroes Behind CAR-T Breakthrough
In this special edition of CureTalk, we step beyond the headlines and into the heart of medical innovation. CAR-T therapy has transformed cancer treatment — but its potential stretches far beyond oncology. Behind every breakthrough lies a story of dedication,…
UltraCAR-T Therapy – Scope & Possibilities in Multiple Myeloma Management
Ongoing clinical trials are investigating the safety and efficacy of a new type of CAR T (Chimeric antigen receptor T-cells) therapy called UltraCAR-T therapy for myeloid malignancies. Unlike current CAR T cells, which utilize viruses to attach the CAR to…
ASH 2020 Updates: CAR T Cell Therapies in Multiple Myeloma
We kickstart the new year with a discussion on CAR T cells in myeloma treatment with a focus on the CT053, a CAR T-cell therapy targeting the BCMA protein and granted orphan drug status by the U.S. Food and Drug…